-- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy --...
Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant...
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
BRISBANE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform...
The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients...
NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global voice speech recognition...
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or...
Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at the Tencent WE...
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership...
AUSTIN, Texas, Nov. 15, 2024 /PRNewswire/ -- Today, Mindbloom, the largest provider of psychedelic therapy, and Happier, the leading meditation and...
Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025Company...
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- As the global leader in advanced MRI post-processing solutions, Cortechs.ai is proud to highlight...
LAKE NONA, Fla., Nov. 14, 2024 /PRNewswire/ -- Fountain Life, a longevity, preventative health, advanced diagnostics, and therapeutics company, today...
Athlete-controlled platform solves persistent problems around transparent, portable and accessible health data VANCOUVER, BC, Nov. 14, 2024 /CNW/ - Unify.Health, which...
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria...
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
LISBON, Portugal, Nov. 13, 2024 /PRNewswire/ -- The BHOUT Bag, world's first "punching bag with a brain" developed by Portuguese...
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp....
Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024...